FDA Inspection 861864 — Advarra IRB
The FDA completed an inspection of Advarra IRB on January 7, 2014 in Columbia, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 7, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Columbia, MD (United States)
Additional Details
IRB